Gastrointestinal adverse events Compared with placebo, nausea was more frequent with all tirzepatide doses, especially 15 mg (OR 5.60 [95% CI 3.12, 10.06], I 2 0%) (Table 2)
For some, the anxiety around self-injection is a significant barrier to starting or continuing treatment
1 These products feature portion-controlled options, such as grain bowls, mini flatbread pizzas with cauliflower crust, and high-protein sandwich melts designed to support the nutritional needs of individuals consuming smaller portions due to medication-induced appetite suppression
Association of bariatric surgery with cardiovascular outcomes in adults with severe obesity and nonalcoholic fatty liver disease
Special Considerations and Interactions FDA-Approved Oral Semaglutide May Not Work Well If You Have: Gastrointestinal disorders affecting absorption Liver conditions Difficulty maintaining strict morning medication routines Compounded ODT Formulations Considerations: Not FDA-approved
Probiotics: Fact sheet for health professionals
